INFLUENCE OF OMEGA-3 HIGHER LONG-CHAIN POLYUNSATURATED FATTY ACIDS ON SOME PARAMETERS OF METABOLISM, AMBULATORY BLOOD PRESSURE MONITORING IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR AUTONOMIC NEUROPATHY
Sergienko Viktoriya Aleksandrovna
Danylo Halytsky Lviv National Medical University, Ukraine
Abstract. The aim of this study was the assessment of some blood lipid profile indicators, the parameters of ambulatory blood pressure monitoring (ABPM) in patients with type 2 diabetes mellitus (DM) and cardiovascular autonomic neuropathy (CAN) before and after omega-3 long-chain polyunsaturated fatty acids (omega-3 PUFA) administration. It was established that treatment with omega-3 PUFA contributes to the positive changes of high density lipoprotein cholesterol and triglyceride concentration, is accompanied by the tendency to the normalization of some ABPM parameters. The obtained results argue for the advisability of omega-3 PUFA use in the complex therapy of patients with type 2 DM and CAN.
Key words and phrases: сахарный диабет 2-го типа, кардиоваскулярная автономная нейропатия, длинноцепочечные омега-3 полиненасыщенные жирные кислоты, липиды, суточный мониторинг артериального давления, type 2 diabetes mellitus, cardiovascular autonomic neuropathy, w-3 long-chain
Open the whole article in PDF format. Free PDF-files viewer can be downloaded .
References:
Gorokhova S. G., Starostina E. G., Arakelyants A. A. Sutochnoe monitorirovanie arterial'nogo davleniya. Osobennosti u bol'nykh sakharnym diabetom i arterial'noi gipertoniei. M.: N'YuDIAMED, 2006. 51 s.
Zelveyan P. A., Buniatyan M. S., Oshchepkova E. V. Sutochnyi ritm arterial'nogo davleniya: klinicheskoe znachenie i prognosticheskaya tsennost' // Kardiologiya. 2002. № 1. C. 55-58.
Lapach S. N., Chubenko A. V., Babich P. N. Statisticheskie metody v mediko-biologicheskikh issledovaniyakh s ispol'zovaniem Excel. Kiev: Morion, 2000. 320 s.
Sergієnko V. O., Sergієnko O. O., Єfіmov A. S. Dovgolantsyugovі w-3 vishchі polіnenasichenі zhirnі kisloti: sertsevo-sudinnі zakhvoryuvannya і tsukrovii dіabet (oglyad lіteraturi ta vlasnikh doslіdzhen') // Zhurnal NAMN Ukrainy. 2011. № 4. S. 353-367.
Pop-Busui R. Cardiac Autonomic Neuropathy in Diabetes: a Clinical Perspective // Diabetes Care. 2010. № 2. P. 434-441.
Roos B. de, Mavrommatis Y., Brouwer I. A. Long-Chain n-3 Polyunsaturated Fatty Acids: New Insights into Mechanisms Relating to Inflammation and Coronary Heart Disease // British Journal of Pharmacology. 2009. № 1. P. 413-428.
Serhiyenko A., Serhiyenko V., Urbanovich A., Serhiyenko L. Effects of the Omega-3 Polyunsaturated Fatty Acids in the Treatment of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus Patients // Endocrine Abstracts. 2008. № 4.
Tesfaye S., Boulton A. J. M., Dyck P. J. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments // Diabetes Care. 2010. № 10. P. 2285-2293.
Vinik A. I., Maser R. E., Ziegler D. Neuropathy: the Crystal Ball for Cardiovascular Disease? // Diabetes Care. 2010. № 7. P. 1688-1690.
Wanders D., Plaisance E. P., Judd R. L. Pharmacological Effects of Lipid-Lowering Drugs on Circulating Adipokines // The World Journal of Diabetes. 2010. № 1. P. 116-128.
World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. World Medical Association, 2004. 32 p.
Русский
